Literature DB >> 14514003

Acute poisonings with Breynia officinalis--an outbreak of hepatotoxicity.

Tzeng-Jih Lin1, Ching-Chyuan Su, Chi-Kin Lan, Donald D Jiang, Jin-Lian Tsai, Mee-Sun Tsai.   

Abstract

BACKGROUND: In combination with other traditional Chinese medicines, Breynia officinalis, a species of Euphorbiaceae, has long been used to treat contusions, heart failure, venereal diseases, growth retardation, and conjunctivitis. B. officinalis, regarded as a poison, was mistaken for a similar plant, Securinega suffruticosa, and cooked in a soup used for the treatment of muscle soreness, lumbago, and as a tonic in this outbreak. CASE SERIES: Nineteen patients, 11 males and 8 females (average age 49.2 +/- 9.1 years) consumed an average of 130 mL (30-900 mL) of soup containing B. officinalis stems. Fourteen patients developed diarrhea, 10 experienced nausea and chilly sensations, 9 had sensations of abdominal fullness, and 7 suffered from vomiting. The results of liver function tests (LFTs) indicated that the observed maximum median level of alanine aminotransferase (ALT) was 647U/L (range 89-9440 U/L), aspartate aminotransferase (AST) 314 U/L (range 47-7756 U/L), alkaline phosphatase 251 U/L (range 224-278 U/L), and gamma glutamyl transpeptidase 106 U/L (range 84-313 U/L). The median time to the observed median peak levels was 3 days for ALT, 2 days for AST, 5 days for alkaline phosphatase, and 12 days for gamma glutamyl transpeptidase. With supportive treatment, the majority of abnormalities in 14 of the cases resolved within 6 months of exposure.
CONCLUSIONS: The consumption of a soup containing B. officinalis Hemsley resulted in dose-related toxic effects. Clinical toxicity consisted primarily of gastrointestinal symptoms and signs and hepatotoxicity. Hepatocellular liver injury rather than cholestatic liver injury was observed. Marked jaundice did not develop.

Entities:  

Mesh:

Year:  2003        PMID: 14514003     DOI: 10.1081/clt-120023760

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  8 in total

Review 1.  Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.

Authors:  Rolf Teschke; Dominique Larrey; Dieter Melchart; Gaby Danan
Journal:  Medicines (Basel)       Date:  2016-07-19

2.  Effect of oral administration of aqueous whole extract of cassytha filiformis on haematograms and plasma biochemical parameters in rats.

Authors:  Hausatu M Babayi; Joseph J I Udeme; Joseph A Abalaka; Joseph I Okogun; O A Salawu; David D Akumka; Sunday S Zarma; Bulus B Adzu; Sabo S Abdulmumuni; Kolo Ibrahime; Baba B Elisha; Samuel S Zakariys; Uford S Inyang
Journal:  J Med Toxicol       Date:  2007-12

3.  Protective role ofPhyllanthus niruri against nimesulide induced hepatic damage.

Authors:  Mary Chatterjee; Parames C Sil
Journal:  Indian J Clin Biochem       Date:  2007-03

Review 4.  Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps.

Authors:  Rolf Teschke; Axel Eickhoff
Journal:  Front Pharmacol       Date:  2015-04-23       Impact factor: 5.810

Review 5.  Traditional Chinese Medicine Induced Liver Injury.

Authors:  Rolf Teschke
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

6.  Literature Review of Traditional Chinese Medicine Herbs-Induced Liver Injury From an Oncological Perspective With RUCAM.

Authors:  Hei Ching Chow; Tsz Him So; Horace Cheuk Wai Choi; Ka On Lam
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

Review 7.  Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.

Authors:  Christian Frenzel; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2016-04-27       Impact factor: 5.923

8.  Evaluation of cytotoxic effects and acute and chronic toxicity of aqueous extract of the seeds of Calycotome villosa (Poiret) Link (subsp. intermedia) in rodents.

Authors:  Badiaa Lyoussi; Khadija Cherkaoui Tangi; Nicole Morel; Mohamed Haddad; Joelle Quetin-Leclercq
Journal:  Avicenna J Phytomed       Date:  2018 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.